Correlation Between Visa and Propanc Biopharma

Can any of the company-specific risk be diversified away by investing in both Visa and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Propanc Biopharma, you can compare the effects of market volatilities on Visa and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Propanc Biopharma.

Diversification Opportunities for Visa and Propanc Biopharma

-0.36

Correlation Coefficient

Visa  Propanc Biopharma

Very good diversification

The 3 months correlation between Visa and Propanc is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of Visa i.e., Visa and Propanc Biopharma go up and down completely randomly.

Pair Corralation between Visa and Propanc Biopharma

Taking into account the 90-day investment horizon Visa is expected to generate 14.35 times less return on investment than Propanc Biopharma. But when comparing it to its historical volatility, Visa Class A is 25.08 times less risky than Propanc Biopharma. It trades about 0.06 of its potential returns per unit of risk. Propanc Biopharma is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Propanc Biopharma on September 28, 2024 and sell it today you would lose (0.01) from holding Propanc Biopharma or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Visa Class A  vs.  Propanc Biopharma

Visa Class A

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.

Propanc Biopharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Visa and Propanc Biopharma

The main advantage of trading using opposite Visa and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.

The idea behind Visa Class A and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.